Get notified when SONM files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsDNA X terminates $500M equity financing facility with Chardan Capital Markets
Filed June 4, 2026 · Period ending May 29, 2026 · ~1 min read
Key Changes
-
high
DNA X and Chardan Capital Markets mutually terminated the ChEF Purchase Agreement effective May 28, 2026, ending a facility that allowed the company to sell up to $500 million in common stock on demand.
Item 1.01 view on EDGAR → -
high
The company no longer has access to this committed equity financing mechanism, which was established in September 2025 and may now need to pursue alternative capital-raising arrangements.
Item 1.01 view on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.
Partner
Trade SONM commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify